Cargando…
Hepatic glycogen storage diseases are associated to microbial dysbiosis
INTRODUCTION: The gut microbiome has been related to several features present in Glycogen Storage Diseases (GSD) patients including obesity, inflammatory bowel disease (IBD) and liver disease. OBJECTIVES: The primary objective of this study was to investigate associations between GSD and the gut mic...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6445422/ https://www.ncbi.nlm.nih.gov/pubmed/30939160 http://dx.doi.org/10.1371/journal.pone.0214582 |
_version_ | 1783408190635900928 |
---|---|
author | Colonetti, Karina Bento dos Santos, Bruna Nalin, Tatiéle Moura de Souza, Carolina Fischinger Triplett, Eric W. Dobbler, Priscila Thiago Schwartz, Ida Vanessa Doederlein Roesch, Luiz Fernando Wurdig |
author_facet | Colonetti, Karina Bento dos Santos, Bruna Nalin, Tatiéle Moura de Souza, Carolina Fischinger Triplett, Eric W. Dobbler, Priscila Thiago Schwartz, Ida Vanessa Doederlein Roesch, Luiz Fernando Wurdig |
author_sort | Colonetti, Karina |
collection | PubMed |
description | INTRODUCTION: The gut microbiome has been related to several features present in Glycogen Storage Diseases (GSD) patients including obesity, inflammatory bowel disease (IBD) and liver disease. OBJECTIVES: The primary objective of this study was to investigate associations between GSD and the gut microbiota. METHODS: Twenty-four GSD patients on treatment with uncooked cornstarch (UCCS), and 16 healthy controls had their faecal microbiota evaluated through 16S rRNA gene sequencing. Patients and controls were ≥3 years of age and not on antibiotics. Faecal pH, calprotectin, mean daily nutrient intake and current medications were recorded and correlated with gut microbiome. RESULTS: Patients’ group presented higher intake of UCCS, higher prevalence of IBD (n = 04/24) and obesity/overweight (n = 18/24) compared to controls (n = 0 and 06/16, respectively). Both groups differed regarding diet (in patients, the calories’ source was mainly the UCSS, and the intake of fat, calcium, sodium, and vitamins was lower than in controls), use of angiotensin-converting enzyme inhibitors (patients = 11, controls = 0; p-value = 0.001) multivitamins (patients = 22, controls = 01; p-value = 0.001), and mean faecal pH (patients = 6.23; controls = 7.41; p = 0.001). The GSD microbiome was characterized by low diversity and distinct microbial structure. The operational taxonomic unit (OTU) abundance was significantly influenced by faecal pH (r = 0.77; p = 6.8e-09), total carbohydrate (r = -0.6; p = 4.8e-05) and sugar (r = 0.057; p = 0.00013) intakes. CONCLUSIONS: GSD patients presented intestinal dysbiosis, showing low faecal microbial diversity in comparison with healthy controls. Those findings might be due to the disease per se, and/or to the different diets, use of UCSS and of medicines, and obesity rate found in patients. Although the main driver of these differences is unknown, this study might help to understand how the nutritional management affects GSD patients. |
format | Online Article Text |
id | pubmed-6445422 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-64454222019-04-17 Hepatic glycogen storage diseases are associated to microbial dysbiosis Colonetti, Karina Bento dos Santos, Bruna Nalin, Tatiéle Moura de Souza, Carolina Fischinger Triplett, Eric W. Dobbler, Priscila Thiago Schwartz, Ida Vanessa Doederlein Roesch, Luiz Fernando Wurdig PLoS One Research Article INTRODUCTION: The gut microbiome has been related to several features present in Glycogen Storage Diseases (GSD) patients including obesity, inflammatory bowel disease (IBD) and liver disease. OBJECTIVES: The primary objective of this study was to investigate associations between GSD and the gut microbiota. METHODS: Twenty-four GSD patients on treatment with uncooked cornstarch (UCCS), and 16 healthy controls had their faecal microbiota evaluated through 16S rRNA gene sequencing. Patients and controls were ≥3 years of age and not on antibiotics. Faecal pH, calprotectin, mean daily nutrient intake and current medications were recorded and correlated with gut microbiome. RESULTS: Patients’ group presented higher intake of UCCS, higher prevalence of IBD (n = 04/24) and obesity/overweight (n = 18/24) compared to controls (n = 0 and 06/16, respectively). Both groups differed regarding diet (in patients, the calories’ source was mainly the UCSS, and the intake of fat, calcium, sodium, and vitamins was lower than in controls), use of angiotensin-converting enzyme inhibitors (patients = 11, controls = 0; p-value = 0.001) multivitamins (patients = 22, controls = 01; p-value = 0.001), and mean faecal pH (patients = 6.23; controls = 7.41; p = 0.001). The GSD microbiome was characterized by low diversity and distinct microbial structure. The operational taxonomic unit (OTU) abundance was significantly influenced by faecal pH (r = 0.77; p = 6.8e-09), total carbohydrate (r = -0.6; p = 4.8e-05) and sugar (r = 0.057; p = 0.00013) intakes. CONCLUSIONS: GSD patients presented intestinal dysbiosis, showing low faecal microbial diversity in comparison with healthy controls. Those findings might be due to the disease per se, and/or to the different diets, use of UCSS and of medicines, and obesity rate found in patients. Although the main driver of these differences is unknown, this study might help to understand how the nutritional management affects GSD patients. Public Library of Science 2019-04-02 /pmc/articles/PMC6445422/ /pubmed/30939160 http://dx.doi.org/10.1371/journal.pone.0214582 Text en © 2019 Colonetti et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Colonetti, Karina Bento dos Santos, Bruna Nalin, Tatiéle Moura de Souza, Carolina Fischinger Triplett, Eric W. Dobbler, Priscila Thiago Schwartz, Ida Vanessa Doederlein Roesch, Luiz Fernando Wurdig Hepatic glycogen storage diseases are associated to microbial dysbiosis |
title | Hepatic glycogen storage diseases are associated to microbial dysbiosis |
title_full | Hepatic glycogen storage diseases are associated to microbial dysbiosis |
title_fullStr | Hepatic glycogen storage diseases are associated to microbial dysbiosis |
title_full_unstemmed | Hepatic glycogen storage diseases are associated to microbial dysbiosis |
title_short | Hepatic glycogen storage diseases are associated to microbial dysbiosis |
title_sort | hepatic glycogen storage diseases are associated to microbial dysbiosis |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6445422/ https://www.ncbi.nlm.nih.gov/pubmed/30939160 http://dx.doi.org/10.1371/journal.pone.0214582 |
work_keys_str_mv | AT colonettikarina hepaticglycogenstoragediseasesareassociatedtomicrobialdysbiosis AT bentodossantosbruna hepaticglycogenstoragediseasesareassociatedtomicrobialdysbiosis AT nalintatiele hepaticglycogenstoragediseasesareassociatedtomicrobialdysbiosis AT mouradesouzacarolinafischinger hepaticglycogenstoragediseasesareassociatedtomicrobialdysbiosis AT triplettericw hepaticglycogenstoragediseasesareassociatedtomicrobialdysbiosis AT dobblerpriscilathiago hepaticglycogenstoragediseasesareassociatedtomicrobialdysbiosis AT schwartzidavanessadoederlein hepaticglycogenstoragediseasesareassociatedtomicrobialdysbiosis AT roeschluizfernandowurdig hepaticglycogenstoragediseasesareassociatedtomicrobialdysbiosis |